Development of a Gram-negative selective agar (GNSA) for the detection of Gram-negative microflora in sputa in patients with cystic fibrosis.
about
Genomic Potential of Stenotrophomonas maltophilia in Bioremediation with an Assessment of Its Multifaceted Role in Our EnvironmentStenotrophomonas maltophilia: an emerging global opportunistic pathogenShared genotypes of Achromobacter xylosoxidans strains isolated from patients at a cystic fibrosis rehabilitation center.
P2860
Development of a Gram-negative selective agar (GNSA) for the detection of Gram-negative microflora in sputa in patients with cystic fibrosis.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh
2003年學術文章
@zh-hant
name
Development of a Gram-negative ...... patients with cystic fibrosis.
@en
Development of a Gram-negative selective agar
@nl
type
label
Development of a Gram-negative ...... patients with cystic fibrosis.
@en
Development of a Gram-negative selective agar
@nl
prefLabel
Development of a Gram-negative ...... patients with cystic fibrosis.
@en
Development of a Gram-negative selective agar
@nl
P2093
P2860
P1476
Development of a Gram-negative ...... patients with cystic fibrosis.
@en
P2093
P2860
P304
P356
10.1046/J.1365-2672.2003.01956.X
P577
2003-01-01T00:00:00Z